Kewaunee Scientific Statistics
Kewaunee Scientific (KEW) Stock Statistics & Valuation Metrics
Total Valuation
Kewaunee Scientific has a market cap or net worth of EUR 93.78M. The enterprise value is EUR 151.76M.
- Market Cap
- EUR 93.78M
- Enterprise Value
- EUR 151.76M
Share Statistics
Kewaunee Scientific has 2,895,347 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 2,895,347
- Owned by Insiders
- 6.41%
- Owned by Institutions
- 32.34%
Financial Efficiency
Kewaunee Scientific’s return on equity (ROE) is 0.13 and return on invested capital (ROIC) is 9.18%.
- Return on Equity (ROE)
- 0.13
- Return on Assets (ROA)
- 0.05
- Return on Invested Capital (ROIC)
- 9.18%
- Return on Capital Employed (ROCE)
- 0.13
- Revenue Per Employee
- 229.08K
- Profits Per Employee
- 7,813.16
- Employee Count
- 1,231
- Asset Turnover
- 1.58
- Inventory Turnover
- 6.60
Valuation Ratios
The current PE Ratio of Kewaunee Scientific is 12.48. Kewaunee Scientific’s PEG ratio is -0.37.
- PE Ratio
- 12.48
- PS Ratio
- 0.37
- PB Ratio
- 1.37
- Price to FCF
- 9.50
- Price to Operating Cash Flow
- 6.94
- PEG Ratio
- -0.37
Income Statement
In the last 12 months, Kewaunee Scientific had revenue of 282.00M and earned 9.62M in profits. Earnings per share was 3.36.
- Revenue
- 282.00M
- Gross Profit
- 80.44M
- Operating Income
- 16.71M
- Pretax Income
- 13.73M
- Net Income
- 9.62M
- EBITDA
- 23.88M
- Earnings Per Share (EPS)
- 3.36
Cash Flow
In the last 12 months, operating cash flow was 14.82M and capital expenditures -3.94M, giving a free cash flow of 10.88M billion.
- Operating Cash Flow
- 14.82M
- Free Cash Flow
- 10.88M
- Free Cash Flow per Share
- 3.78
Dividends & Yields
Kewaunee Scientific pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 10.53%
- Earnings Yield
- 8.01%
Stock Price Statistics
- Beta
- 0.81
- 52-Week Price Change
- -5.78%
- 50-Day Moving Average
- 29.79
- 200-Day Moving Average
- 31.35
- Relative Strength Index (RSI)
- 66.10
- Average Volume (3m)
- 350
Important Dates
Kewaunee Scientific upcoming earnings date is Dec 16, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Sep 09, 2026
- Next Earnings Date
- Dec 16, 2026
- Ex-Dividend Date
- ―
Financial Position
Kewaunee Scientific as a current ratio of 2.18, with Debt / Equity ratio of 40.40%
- Current Ratio
- 2.18
- Quick Ratio
- 1.55
- Debt to Market Cap
- 0.19
- Net Debt to EBITDA
- 0.78
- Interest Coverage Ratio
- 4.33
Taxes
In the past 12 months, Kewaunee Scientific has paid 3.27M in taxes.
- Income Tax
- 3.27M
- Effective Tax Rate
- 0.24
Enterprise Valuation
Kewaunee Scientific EV to EBITDA ratio is 6.81, with an EV/FCF ratio of 13.84.
- EV to Sales
- 0.54
- EV to EBITDA
- 6.81
- EV to Free Cash Flow
- 13.84
- EV to Operating Cash Flow
- 10.16
Balance Sheet
Kewaunee Scientific has EUR 8.25M in cash and marketable securities with EUR 55.47M in debt, giving a net cash position of -EUR 47.23M billion.
- Cash & Marketable Securities
- EUR 8.25M
- Total Debt
- EUR 55.47M
- Net Cash
- -EUR 47.23M
- Net Cash Per Share
- -EUR 16.31
- Tangible Book Value Per Share
- EUR 16.95
Margins
Gross margin is 28.55%, with operating margin of 5.43%, and net profit margin of 2.97%.
- Gross Margin
- 28.55%
- Operating Margin
- 5.43%
- Pretax Margin
- 4.46%
- Net Profit Margin
- 2.97%
- EBITDA Margin
- 7.97%
- EBIT Margin
- 5.69%
Analyst Forecast
The average price target for Kewaunee Scientific is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -1.10%
- EPS Growth Forecast
- -37.16%
Scores
- Smart Score
- 4
- AI Score
- ―

